Innate's Lirilumab In Limbo After Phase II Combo Failure

 
• By Lucie Ellis-Taitt
  
Swing
Future of Innate/BMS's lirilumab hangs in the balance • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D